Urine Analysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Urine Analysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies


Summary

GlobalData's Medical Devices sector report, “Urine Analysis Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Urine Analysis pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Urine analysis is the analysis of urine to aid in the diagnosis of disease or to detect the presence of a specific substance.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Urine Analysis under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Urine Analysis and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Urine Analysis under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Urine Analysis Overview
4 Products under Development
4.1 Urine Analysis - Pipeline Products by Stage of Development
4.2 Urine Analysis - Pipeline Products by Segment
4.3 Urine Analysis - Pipeline Products by Territory
4.4 Urine Analysis - Pipeline Products by Regulatory Path
4.5 Urine Analysis - Pipeline Products by Estimated Approval Date
5 Urine Analysis - Pipeline Products under Development by Companies
5.1 Urine Analysis Companies - Pipeline Products by Stage of Development
5.2 Urine Analysis – Companies Pipeline Products by Stage of Development
6 Urine Analysis Companies and Product Overview
6.1 A.Menarini Diagnostics Ltd Company Overview
6.1.1 A.Menarini Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.2 Analyticon Biotechnologies AG Company Overview
6.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
6.3 Astrego Diagnostics AB Company Overview
6.3.1 Astrego Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview
6.4 Bisu Inc Company Overview
6.4.1 Bisu Inc Pipeline Products & Ongoing Clinical Trials Overview
6.5 California Pacific Medical Center Research Institute Company Overview
6.5.1 California Pacific Medical Center Research Institute Pipeline Products & Ongoing Clinical Trials Overview
6.6 Clinical Design Technologies Ltd Company Overview
6.6.1 Clinical Design Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.7 Eone Diagnomics Genome Center Co Ltd Company Overview
6.7.1 Eone Diagnomics Genome Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.8 First Light Diagnostics Inc Company Overview
6.8.1 First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.9 Healthy io Ltd Company Overview
6.9.1 Healthy io Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.1 Imperial College London Company Overview
6.10.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
6.11 Indian Institute of Technology Delhi Company Overview
6.11.1 Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview
6.12 IRIS International Inc Company Overview
6.12.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
6.13 LifeAssays AB Company Overview
6.13.1 LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview
6.14 NTBIO Diagnostics Inc Company Overview
6.14.1 NTBIO Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.15 QSTAG Co Ltd Company Overview
6.15.1 QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.16 Sebia Company Overview
6.16.1 Sebia Pipeline Products & Ongoing Clinical Trials Overview
6.17 Siemens Healthcare Diagnostics Inc Company Overview
6.17.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.18 Singapore General Hospital Company Overview
6.18.1 Singapore General Hospital Pipeline Products & Ongoing Clinical Trials Overview
6.19 Stanford University Company Overview
6.19.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
6.2 Teco Diagnostics Company Overview
6.20.1 Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
6.21 University of Kentucky Company Overview
6.21.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview
6.22 Withings SA Company Overview
6.22.1 Withings SA Pipeline Products & Ongoing Clinical Trials Overview
7 Urine Analysis- Recent Developments
7.1 Sep 11, 2023: Dirui Industrial Appoints Lin Maoliang as Non-Independent Directors
7.2 Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
7.3 Jul 10, 2023: Keystone Lab Announces Addition of Xylazine Testing to Its In-House Menu
7.4 Jun 20, 2023: Veravas Launches Groundbreaking VeraBIND Technology for Ultra-Sensitive Assays and Matrix Free Sample Analysis
7.5 May 12, 2023: Horiba announces summary of consolidated financial statements for the three months ended March 31, 2023
7.6 Apr 03, 2023: Shanghai Kehua's Board Elects Li Ming As Company President
7.7 Mar 28, 2023: EKF Diagnostics Holdings Announces its final results for the year ended 31 December 2022
7.8 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
7.9 Feb 14, 2023: Horiba Announces Summary of Consolidated Financial Statements for the Year Ended December 31, 2022
7.1 Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
7.11 Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors
7.12 Feb 01, 2023: Techno Medica Announces Non-consolidated Financial Results for the Nine Months Ended December 31,2022
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Urine Analysis - Pipeline Products by Stage of Development
Table 2: Urine Analysis - Pipeline Products by Segment
Table 3: Urine Analysis - Pipeline Products by Territory
Table 4: Urine Analysis - Pipeline Products by Regulatory Path
Table 5: Urine Analysis - Pipeline Products by Estimated Approval Date
Table 6: Urine Analysis Companies - Pipeline Products by Stage of Development
Table 7: Urine Analysis – Companies Pipeline Products by Stage of Development
Table 8: A.Menarini Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Sedimax Lite - Product Status
Table 10: Sedimax Lite - Product Description
Table 11: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Urilyzer 100 Pro - Product Status
Table 13: Urilyzer 100 Pro - Product Description
Table 14: Urilyzer 500 Pro - Product Status
Table 15: Urilyzer 500 Pro - Product Description
Table 16: Astrego Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview
Table 17: PA-100 Analyser With PA AST Panel U-0501 - Product Status
Table 18: PA-100 Analyser With PA AST Panel U-0501 - Product Description
Table 19: Bisu Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Bisu Body Coach - Product Status
Table 21: Bisu Body Coach - Product Description
Table 22: Fertility Test Stick - Product Status
Table 23: Fertility Test Stick - Product Description
Table 24: Oral Health Test Stick - Product Status
Table 25: Oral Health Test Stick - Product Description
Table 26: California Pacific Medical Center Research Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Urinary Proteome Monitoring Assay - Product Status
Table 28: Urinary Proteome Monitoring Assay - Product Description
Table 29: Clinical Design Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Urine Testing System - Product Status
Table 31: Urine Testing System - Product Description
Table 32: Eone Diagnomics Genome Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Uriwell - Product Status
Table 34: Uriwell - Product Description
Table 35: First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: MultiPath Immunoreagent - UTI - Product Status
Table 37: MultiPath Immunoreagent - UTI - Product Description
Table 38: Healthy io Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Home Based Dipstick Analyzer - Skincare - Product Status
Table 40: Home Based Dipstick Analyzer - Skincare - Product Description
Table 41: Minuteful 10 - Product Status
Table 42: Minuteful 10 - Product Description
Table 43: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Diagnostic Test - Autism - Product Status
Table 45: Diagnostic Test - Autism - Product Description
Table 46: Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Opto-Electronic Sensor - Micro-Albumin - Product Status
Table 48: Opto-Electronic Sensor - Micro-Albumin - Product Description
Table 49: IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: GEMS Next Generation Urinalysis Platform - Product Status
Table 51: GEMS Next Generation Urinalysis Platform - Product Description
Table 52: LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview
Table 53: LifeAssays U-Albumin - Product Status
Table 54: LifeAssays U-Albumin - Product Description
Table 55: NTBIO Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Urine Analyzer - Product Status
Table 57: Urine Analyzer - Product Description
Table 58: QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Qscheck-UIS Ketogenic Diet Kit - Product Status
Table 60: Qscheck-UIS Ketogenic Diet Kit - Product Description
Table 61: Qscheck-UIS4 Kit - Product Status
Table 62: Qscheck-UIS4 Kit - Product Description
Table 63: Sebia Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Capillarys 3 Tera Assay - Urine - Product Status
Table 65: Capillarys 3 Tera Assay - Urine - Product Description
Table 66: Capillarys 3 Tera Assay - Urine IT - Product Status
Table 67: Capillarys 3 Tera Assay - Urine IT - Product Description
Table 68: Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Clinitek Atlas Next - Product Status
Table 70: Clinitek Atlas Next - Product Description
Table 71: Singapore General Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Urine Biochemistry Device - Product Status
Table 73: Urine Biochemistry Device - Product Description
Table 74: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Biostrip Test - Urine Analysis - Product Status
Table 76: Biostrip Test - Urine Analysis - Product Description
Table 77: Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Next Generation Urine Analyzer - Product Status
Table 79: Next Generation Urine Analyzer - Product Description
Table 80: University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Diagnostic Gene-Expression Test - Interstitial Cystitis - Product Status
Table 82: Diagnostic Gene-Expression Test - Interstitial Cystitis - Product Description
Table 83: Withings SA Pipeline Products & Ongoing Clinical Trials Overview
Table 84: U-Scan - Product Status
Table 85: U-Scan - Product Description
Table 86: Glossary
2.2 List of Figures
Figure 1: Urine Analysis - Pipeline Products by Stage of Development
Figure 2: Urine Analysis - Pipeline Products by Segment
Figure 3: Urine Analysis - Pipeline Products by Territory
Figure 4: Urine Analysis - Pipeline Products by Regulatory Path
Figure 5: Urine Analysis - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings